Depression in CKD and the need for integrated care
Chronic kidney disease is a significant and growing public health challenge, affecting millions of people worldwide and burdening patients, families, and healthcare systems.1 Although clinical management has traditionally focused on slowing disease progression and managing physical complications, the role of mental health in patient outcomes is increasingly recognized. In particular, depression has emerged as a common yet often underrecognized condition that can profoundly influence the trajectory of chronic illness.2
Common Conditions With a Complex Link
CKD is defined as abnormalities in kidney structure or function that persist for more than 3 months and have adverse health implications. The CDC estimates that more than 1 in 10 adults, approximately 37 million individuals, in the United States have CKD. Notably, 9 out of 10 individuals with CKD are unaware of their condition, and 40% of those with severely reduced kidney function who are not on dialysis remain undiagnosed.3
Depression is one of the most common mental health conditions worldwide, affecting an estimated 332 million people. Approximately 5.7% of adults worldwide experience depression (4.6% of men and 6.9% of women).4 Characterized by persistent sadness, hopelessness, and loss of interest in daily activities, depression may be long-lasting or recurrent and can significantly impair an individual’s ability to manage their health, maintain relationships, and engage in treatment.5
Depression affects approximately 23.7% of individuals with CKD. The relationship between depression and CKD is complex and bidirectional. Depression may contribute to the development and progression of CKD by promoting adverse health behaviors, including smoking, physical inactivity, and obesity. These behaviors can worsen underlying conditions such as diabetes and hypertension, which are primary risk factors for CKD. Depressive symptoms are also more common among individuals with diabetes, further compounding risk.6
Patients with CKD face significant physical and treatment-related burdens that contribute to depression. Uremic symptoms, dialysis-related effects, and medication side effects, such as gastrointestinal discomfort from phosphate binders, are often linked to increased psychological distress. As CKD progresses, the prevalence of depression rises, with higher rates observed in patients receiving dialysis (34.5%).7 The cumulative burden of chronic illness, complex treatment regimens, and lifestyle disruptions further increases vulnerability to depression.
Importantly, depression in CKD is associated with increased mortality and should not be viewed merely as a comorbidity. Rather, it is a critical factor that influences treatment adherence, quality of life, and overall clinical outcomes. Approximately 25% of patients with CKD report symptoms consistent with major depressive disorder, and many remain undertreated.8 Patients with depressive symptoms are more likely to miss dialysis treatments, demonstrate poor medication adherence, and engage less effectively in self-management behaviors. Depression has also been linked to adverse outcomes, including increased hospitalizations, acute kidney injury, CKD progression, and cardiovascular events.9,10
The relationship between depression and CKD further complicates care. As physical health declines, psychological distress may intensify. Conversely, untreated depression can adversely affect physiologic outcomes and disease management. Recognizing and addressing depression is therefore essential to delivering holistic, patient-centered nephrology care. Routine screening, early identification, and timely intervention are key strategies for improving mental health and clinical outcomes, reinforcing the critical role of nephrology nurses in comprehensive patient management.11
Depression Screening and Management
Screening is critical for individuals with CKD because of the strong association between depression, poor clinical outcomes, and reduced quality of life. Screening should begin at the time of CKD diagnosis and continue periodically throughout the disease course. Although the CMS does not mandate a specific screening instrument, the tools used must be validated for depression to ensure accurate assessment.12 Commonly used tools include the Patient Health Questionnaire-9 (PHQ-9), the Beck Depression Inventory (BDI), and the Hamilton Depression Rating Scale.13
Managing depression in patients with CKD requires a multifaceted approach. Cognitive-behavioral therapy and pharmacologic treatment may be appropriate, depending on symptom severity. In addition, nonpharmacologic interventions play a vital role in symptom management. Techniques such as deep breathing, meditation, yoga, progressive muscle relaxation, guided imagery, and mindfulness can reduce stress and anxiety. Support from family, friends, and support groups helps alleviate isolation, while regular physical activity improves mood and overall health.12 Patient education that enhances understanding of CKD and self-management strategies further supports improved outcomes. Collectively, these interventions can reduce depressive symptoms, enhance coping, and improve adherence, quality of life, and clinical outcomes.13, 14
An Essential Part of CKD Care
Depression in CKD is common and consequential, yet it remains underrecognized and undertreated. Its impact extends beyond emotional well-being, affecting treatment adherence, quality of life, healthcare utilization, and overall clinical outcomes. Nephrology nurses are uniquely positioned to identify early signs, implement routine screening, and advocate for timely, evidence-based interventions.
Integrating mental health assessment into standard CKD care is essential to comprehensive, patient-centered care. A proactive, interdisciplinary approach that integrates routine screening, patient education, and pharmacologic and nonpharmacologic interventions can significantly improve patient outcomes. By prioritizing mental health alongside physical health, clinicians can enhance coping, strengthen engagement in care, and reduce disease burden. Addressing depression is a critical step toward improving the lived experience and long-term outcomes for individuals with CKD.
